Sources told ET that the IPO would be of ₹2000 crore – ₹2500 crore size.The issue with a face value of ₹1 per equity share is a complete offer for sale (OFS) aggregating to 20,925,652 equity shares by Helix Investment Holdings Pte. Limited. The offer also includes a reservation for a subscription by eligible employees.
Sources told ET that the IPO would be of ₹2000 crore – ₹2500 crore size.
The issue with a face value of ₹1 per equity share is a complete offer for sale (OFS) aggregating to 20,925,652 equity shares by Helix Investment Holdings Pte. Limited. The offer also includes a reservation for a subscription by eligible employees.
The offer is being made through the book-building process, wherein not more than 50% of the offer shall be available for allocation to qualified institutional buyers, up to 15% will be available for allocation to non-institutional bidders and the remainder for retail investors.
As per DRHP, Concord has a market share of over 20% by volume in 2021 across identified fermentation-based API products including dactinomycin, sirolimus, tacrolimus, and mycophenolate sodium, and cyclosporine. It supplies to over 70 countries including regulated markets such as the US, Europe, Japan, and India.
The company’s revenue from operations increased by 15.6% year-on-year (YoY) to Rs 712.93 crore for FY22.
“What lies behind us and what lies before us are small matters compared to what lies within us.” – Oliver Wendell Holmes
- Front Page
- Pure Politics
- Brands & Companies
- ET Markets
- More
-
Take 5 Pledges to Help India Meet its Goals by 2047: PM
Prime Minister Narendra Modi on Monday gave a call to all Indians to follow “Paanch Pran”, or five resolutions: set high goals, end any trace of a slavery mindset, take pride in the country’s heritage and roots, strive for unity and perform the duty as citizens.
Tata Asset Mgmt Considers Buying 45% in UTI AMC
Tata Group, the promoter of Tata Asset Management Company (AMC), is exploring options to buy about 45% in UTI AMC from four state-owned financial entities, three people with knowledge of the matter told ET.
Jhunjhunwala Demise Unlikely to Affect Akasa Air’s Business
The death of Rakesh Jhunjhunwala, India’s most successful stock investor, is unlikely to have any impact on the business of Akasa Air.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
… more less